103 related articles for article (PubMed ID: 3168257)
1. Macro-prostatic acid phosphatase in a patient's serum.
Schifferli JA; Roth P; Steiger G; Paccaud JP; Schmidt M
Clin Chem; 1988 Oct; 34(10):2172-4. PubMed ID: 3168257
[TBL] [Abstract][Full Text] [Related]
2. Circulating prostatic acid phosphatase-immunoglobulin complexes in Sjogren's syndrome.
Virji MA
Clin Chim Acta; 1985 Oct; 151(3):223-30. PubMed ID: 4053382
[TBL] [Abstract][Full Text] [Related]
3. Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay.
Vihko P; Schroeder FH; Lukkarinen O; Vihko R
J Urol; 1982 Jul; 128(1):202-4. PubMed ID: 6180187
[TBL] [Abstract][Full Text] [Related]
4. Serum half life of prostatic acid phosphatase.
Wadström J; Wenk M; Huber P
Urol Res; 1985; 13(3):131-2. PubMed ID: 4024394
[TBL] [Abstract][Full Text] [Related]
5. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
[TBL] [Abstract][Full Text] [Related]
6. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
Dejter SW; Martin JS; McPherson RA; Lynch JH
Urology; 1988 Oct; 32(4):288-92. PubMed ID: 2459831
[TBL] [Abstract][Full Text] [Related]
7. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
Morote Robles J; de Torres Mateos JA
Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
[TBL] [Abstract][Full Text] [Related]
8. A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
van Dieijen-Visser MP; Delaere KP; Gijzen AH; Brombacher PJ
Clin Chim Acta; 1988 May; 174(2):131-40. PubMed ID: 2454767
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
Mortarelli EA
Ann Clin Lab Sci; 1992; 22(4):201-6. PubMed ID: 1380223
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a new solid-phase direct immunoenzyme assay for prostatic acid phosphatase.
Gericke K; Kohse KP; Pfleiderer G; Flüchter SH; Bichler KH
Clin Chem; 1982 Apr; 28(4 Pt 1):596-602. PubMed ID: 7042116
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
[TBL] [Abstract][Full Text] [Related]
15. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
16. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
Shinoda I
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging.
Goldenberg DM; DeLand FH; Bennett SJ; Primus FJ; Nelson MO; Flanigan RC; McRoberts JW; Bruce AW; Mahan DE
JAMA; 1983 Aug; 250(5):630-5. PubMed ID: 6345831
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of prostatic infarcts and their effect on serum prostate-specific antigen and prostatic acid phosphatase.
Brawn PN; Foster DM; Jay DW; Kuhl D; Speights VO; Johnson EH; Coffield KS; Lind ML; Karl R; Weaver B
Urology; 1994 Jul; 44(1):71-5. PubMed ID: 7518984
[TBL] [Abstract][Full Text] [Related]
20. Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
Dejter SW; Erickson BA; Lynch JH
Urology; 1988 Feb; 31(2):125-8. PubMed ID: 3341096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
